
Microgravity uncovers space phages that could curb antibiotic resistance
A study comparing phage-bacteria dynamics on the ISS and on Earth shows that the T7 phage infecting E. coli slows in microgravity but can still replicate after a long interval. Space conditions drive distinct mutation patterns in both phage and host, and researchers used microgravity-informed mutations to engineer phage variants that outperform Earth-informed ones against drug-resistant uropathogenic E. coli. The findings suggest extreme environments can reveal new design principles for phage therapy to combat antibiotic resistance and are reported in PLOS Biology.













